molybdenum has been researched along with pervanadate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaalhus, O; Mikalsen, SO | 1 |
| Hwang, SA; Jang, SH; Karnik, SS; Kim, M; Kim, MS; Lee, C; Yun, SH | 1 |
2 other study(ies) available for molybdenum and pervanadate
| Article | Year |
|---|---|
Properties of pervanadate and permolybdate. Connexin43, phosphatase inhibition, and thiol reactivity as model systems.
Topics: Animals; Catalase; Cells, Cultured; Connexin 43; Cricetinae; Dose-Response Relationship, Drug; Drug Stability; Embryo, Mammalian; Enzyme Inhibitors; Ethylmaleimide; Gap Junctions; Kinetics; Mesocricetus; Models, Chemical; Molybdenum; Oxides; Phosphorylation; Protein Tyrosine Phosphatases; Structure-Activity Relationship; Sulfhydryl Compounds; Vanadates | 1998 |
A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage.
Topics: Angiotensin II; Animals; Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Green Fluorescent Proteins; Hydrolysis; Molybdenum; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatases; Rats; Receptor, Angiotensin, Type 1; Transfection; Tyrosine; Vanadates; Vasoconstrictor Agents | 2009 |